Schedule 13G/A
Rhea-AI Summary
Avidity Biosciences, Inc. Schedule 13G/A (Amendment No. 3) discloses that RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky and Rajeev Shah are reporting persons for the issuer. The filing incorporates cover-page figures as of March 31, 2026 and states ownership equal to or below 5 percent of the class.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Avidity Biosciences (RNAM) SEC filings are available on StockTitan?
StockTitan tracks 2 SEC filings for Avidity Biosciences (RNAM). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Avidity Biosciences (RNAM)?
The most recent SEC filing for Avidity Biosciences (RNAM) was filed on May 15, 2026.